High-dose opioid prescribing continues to climb

September 12, 2014

TORONTO, Sept. 12, 2014 - High-dose opioid prescribing increased by 23 per cent in Canada between 2006 and 2011, despite clinical guidelines recommending that most patients should avoid high-doses of these drugs, according to new research.

Researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES) found that rates of high-dose opioid dispensing across Canada increased from 781 units per 1,000 people in 2006 to 961 units per 1,000 people in 2011.

"We found that high-dose prescribing was widespread across the country, but the prevalence differed considerably between provinces," said lead author Tara Gomes, a scientist at the Li Ka Shing Knowledge Institute of St. Michael's Hospital. "These findings suggest that although a national strategy is likely necessary, different provinces may need slightly different approaches."

The study, published today in Canadian Family Physician, showed that, high-dose opioid dispensing rates remained relatively stable in Alberta and British Columbia, increasing only 6.3 per cent and 8.4 per cent, respectively. However, rates in Newfoundland and Labrador and Saskatchewan rose substantially (84.7 per cent and 54 per cent, respectively).

Ontario and Quebec exhibited the highest and lowest rates of high-dose opioid dispensing, respectively. Ontario dispensed 1,382 high-dose opioid units per 1,000 people - more than one unit per person - whereas Quebec dispensed only 368 high-dose opioid units per 1,000 people.

"Provinces not only differed in their prevalence of high-dose opioid prescribing, but each province also appears to favour different opioids," said Gomes, who is also a scientist at ICES. "For example, in Alberta and Ontario, oxycodone is the drug most commonly prescribed at high doses, while in British Columbia, it's morphine."

Gomes said there are several potential explanations for the provincial differences in high-dose opioid prescribing, including varying coverage among public drug plans, training among prescribers and differential marketing on the part of pharmaceutical companies.

"Our findings highlight the profound regional variation in high-dose opioid prescribing across Canada," said Gomes. "These results have important public health and policy consequences, given the elevated risk of overdose among individuals treated with high doses of these drugs."

More than 180 million units of high-dose opioid tablets and patches were dispensed across Canada during the six-year study period. Almost half of all the high-dose units dispensed were oxycodone tablets (49 per cent), followed by morphine tablets (24 per cent), hydromorphone tablets (18 per cent) and fentanyl patches (9 per cent).

Canada and the United States have the highest levels of prescription opioid use in the world.

On average, more than 30 million high-dose opioid tablets or patches are dispensed in Canada each year.

Until recently, clinical practice guidelines provided no recommended maximum dose and many experts suggested that the dose could be increased with little risk of harm.

Now, opioid doses equivalent to 200 mg of morphine per day are considered "'watchful doses," according to Canadian clinical practice guidelines. These guidelines, introduced in 2009, recommend clinicians carefully consider the potential risks of addiction and overdose before prescribing a dose that exceeds this threshold.

The per capita rate of high dose opioid dispensing increased steadily in Canada between 2006 and 2008 before plateauing in 2009 and 2010. This plateau coincided with the release of Canadian guidelines for opioids, as well as the first paper showing that the rate of fatal opioid overdoses had increased dramatically in Canada.
-end-
This study was supported by a grant from the Ontario Ministry of Health and Long-Term Care Drug Innovation Fund and ICES.

About St. Michael's Hospital

St. Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in 27 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, care of the homeless and global health are among the hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Centre, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

About ICES

ICES is an independent, non-profit organization that uses population-based health information to produce knowledge on a broad range of health care issues. Our unbiased evidence provides measures of health system performance, a clearer understanding of the shifting health care needs of Ontarians, and a stimulus for discussion of practical solutions to optimize scarce resources. ICES knowledge is highly regarded in Canada and abroad, and is widely used by government, hospitals, planners, and practitioners to make decisions about care delivery and to develop policy.

Media contacts

For more information, or to arrange an interview, please contact:

Geoff Koehler
Adviser, Media Relations
St. Michael's Hospital
416-864-6060 ext. 6537
koehlerg@smh.ca

Deborah Creatura
ICES
deborah.creatura@ices.on.ca
(o) 416-480-4780
(c) 647-406-5996

St. Michael's Hospital

Related Drugs Articles from Brightsurf:

The danger of Z-drugs for dementia patients
Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia, according to new research.

Wallflowers could lead to new drugs
Plant-derived chemicals called cardenolides - like digitoxin - have long been used to treat heart disease, and have shown potential as cancer therapies.

Bristol pioneers use of VR for designing new drugs
Researchers at the University of Bristol are pioneering the use of virtual reality (VR) as a tool to design the next generation of drug treatments.

Towards better anti-cancer drugs
The Bayreuth biochemist Dr. Claus-D. Kuhn and his research team have deciphered how the important human oncogene CDK8 is activated in cells of healthy individuals.

Separating drugs with MagLev
The composition of suspicious powders that may contain illicit drugs can be analyzed using a quick and simple method called magneto-Archimedes levitation (MagLev), according to a new study published in the journal Angewandte Chemie.

People are more likely to try drugs for the first time during the summer
American teenagers and adults are more likely to try illegal or recreational drugs for the first time in the summer, a new study shows.

Drugs used to enhance sexual experiences, especially in UK
Combining drugs with sex is common regardless of gender or sexual orientation, reveals new research by UCL and the Global Drug Survey into global trends of substance-linked sex.

Promising new drugs for old pathogen Mtb
UConn researchers are targeting a metabolic pathway, the dihydrofolate reductase pathway, crucial for amino acid synthesis to treat TB infections.

Can psychedelic drugs heal?
Many people think of psychedelics as relics from the hippie generation or something taken by ravers and music festival-goers, but they may one day be used to treat disorders ranging from social anxiety to depression, according to research presented at the annual convention of the American Psychological Association.

New uses for existing antiviral drugs
Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming.

Read More: Drugs News and Drugs Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.